Construction and expression of a single-chain variable fragment antibody against chicken DEC 205 for targeting the bacterial expressed hemagglutinin-neuraminidase of Newcastle disease virus.
Animals
Antibodies, Neutralizing
/ blood
Antibodies, Viral
/ blood
Antigens, CD
/ immunology
Chickens
/ immunology
Escherichia coli
/ genetics
Hemagglutinins, Viral
/ immunology
Lectins, C-Type
/ immunology
Minor Histocompatibility Antigens
/ immunology
Neuraminidase
/ immunology
Newcastle disease virus
/ enzymology
Poultry Diseases
/ immunology
Receptors, Cell Surface
/ immunology
Recombinant Proteins
/ biosynthesis
Single-Chain Antibodies
/ biosynthesis
Viral Vaccines
/ immunology
Antigen targeting
DEC 205
Hemagglutinin-neuraminidase
Newcastle virus
ScFv
Journal
Veterinary immunology and immunopathology
ISSN: 1873-2534
Titre abrégé: Vet Immunol Immunopathol
Pays: Netherlands
ID NLM: 8002006
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
06
11
2018
revised:
03
05
2019
accepted:
05
05
2019
entrez:
20
6
2019
pubmed:
20
6
2019
medline:
9
8
2019
Statut:
ppublish
Résumé
Targeting antigens to endocytic receptors on the surface of dendritic cells is a new strategy for increasing the adaptive immune response. The objective of the current study was the construction and bacterial expression of a recombinant antibody single-chain fragment variable (ScFv) directed against chicken DEC 205, an endocytic receptor, for use in the genetic fusion of antigens. In particular, we use as antigen the hemagglutinin-neuraminidase (HN) of Newcastle disease virus. Our results show that inoculation of chickens with HN genetically fused to the ScFv anti-DEC 205 induced an evidently higher immune response against HN, in contrast to inoculation with unconjugated HN. In addition, neutralizing antibodies against Newcastle disease virus were detected only in the serum from chickens immunized with HN fused to ScFv anti-DEC 205. Inoculated fused antigens to ScFv against endocytic receptor DEC 205 resulted in a greater antibody-specific anti-HN production compared with antigens applied alone. The results of this study show that the strategy described here has the potential to be used in the development of more effective vaccines against infectious diseases in chickens.
Identifiants
pubmed: 31213252
pii: S0165-2427(18)30441-0
doi: 10.1016/j.vetimm.2019.05.001
pii:
doi:
Substances chimiques
Antibodies, Neutralizing
0
Antibodies, Viral
0
Antigens, CD
0
DEC-205 receptor
0
Hemagglutinins, Viral
0
Lectins, C-Type
0
Minor Histocompatibility Antigens
0
Receptors, Cell Surface
0
Recombinant Proteins
0
Single-Chain Antibodies
0
Viral Vaccines
0
Neuraminidase
EC 3.2.1.18
Types de publication
Journal Article
Langues
eng
Pagination
9-14Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.